Application-specific, efficacious microbial technologies

We have fully characterised our beneficial microbes using the latest in silico and microbiological techniques, enabling us to evidence the safety and efficacy of our microbial and antimicrobial technologies.

Using genomic and Bioinformatic methodologies

We have sequenced the whole genome of our microbial strains and annotated them using our in-house pipeline.

To date we have investigated the following:

  • Toxin gene complement of each strain to understand their safety of use.
  • Antibiotic resistance gene potential to assess if clinically relevant genes of interest are present.
  • Mobile genetic element potential to better define if any AMR genes present can be transferred to the wider microbial community.
  • Secondary metabolite potential to determine the antimicrobial activities and functional potentials of our strains.
  • Extracellular enzyme profiles through which we can better predict which strains are appropriate for the degradation of different polymeric compounds.

How we verify our products: Step-by-step guide

Dr. Emma Saunders details our comprehensive approach to verifying our products, starting with the full characterisation of our beneficial microbes and antimicrobial additives.

Using the most advanced techniques, we thoroughly test our products to confirm their safety and effectiveness, providing you with the assurance you need.

In depth scientific validation and verification is the backbone of our product development processes.

toxin & gmo free

Our products contain no toxins or genetically modified organisms.

No contribution to AMR

Our products don’t contribute to antimicrobial resistance.

Naturally occurring

Our products use naturally occurring materials, including plant extracts and essential oil technology.

Application-specific consortium building

Using genomic profiles we can also identify which Bacillus strains in our library may secrete compounds with commercial, therapeutic and pharmaceutical properties.

Our highly skilled microbiologists apply the latest microbiological techniques to understand how Bacillus grow in different temperature and pHs, in anaerobic and microaerophilic conditions.

They apply both indirect and direct methods to measure:

  • The ability of strains to metabolise (break down) specific substrates, under different environmental conditions.
  • Investigate strain interactions leading to optimum consortium building.
  • Determine the effects of inoculation rate on growth kinetics.

Using all of this data, optimal consortia are designed to meet the specific requirements in the area of application.

Efficacy of our antimicrobial technologies

Our plant derived antimicrobial technology has been fully validated following the 3-phase process as defined in the BS EN 14885:2015 standard. This standard outlines that all disinfectants should be tested using a three-phase method, where each successive phase is harder to pass as it simulates in-use conditions more closely.

Not only are the antimicrobial actives effective according to BS EN1276, BS EN13727, BS EN14776, but our Biosan products have been validated through “real life” testing in FHU, filled with sanitary dressings. In these tests our product provides a 5-log reduction (i.e. a 99.999% kill rate) in gram negative and gram positive bacteria numbers (E.coli and S. aureus) throughout the length of the service cycle.

eco-benign® by design

Genesis Biosciences is fully committed to creating and developing the most environmentally responsible microbial and antimicrobial products available globally. Allow us to introduce you to eco-benign®.

Find out more